Firefly Neuroscience vs Scworx
Scworx is the larger business, with $2.9m of revenue in fiscal 2025 against $1.1m for Firefly Neuroscience (2.5 times as much). Firefly Neuroscience grew faster (957.4% against -3.7%). Scworx kept more of each dollar of sales as profit: a net margin of -154.4% against -1741.0%. Firefly Neuroscience carries less debt relative to equity (0.0% against 0.1%).
| Latest fiscal year | Firefly NeuroscienceAIFF, 2025 | ScworxWORX, 2025 |
|---|---|---|
| Revenue | $1.1m | $2.9m |
| Revenue growth | 957.4% | -3.7% |
| Net income | −$19.9m | −$4.4m |
| Operating margin | -775.5% | -33.3% |
| Net margin | -1741.0% | -154.4% |
| Return on equity | — | -76.3% |
| Free cash flow | −$8.2m | −$1.6m |
| Cash | $2.7m | $1.6m |
| Total debt | $0 | $3,652 |
| Debt to equity | 0.0% | 0.1% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 17 | 9 |
| Market value | $15.7m | $128,547 |
| Price vs our value range | — | — |
| Moat score | 18 (Weak) | 26 (Weak) |
| Insider trades, 12 months | 0 buys, 0 sales | 0 buys, 0 sales |